Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Gyre Therapeutics, Inc. (GYRE) had Days Sales in Receivables of 75.76 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$37.20M |
|
$-1.72M |
|
$1.74M |
|
$35.45M |
|
$37.08M |
|
$0.12M |
|
$-0.18M |
|
$-0.07M |
|
$-0.07M |
|
$-1.37M |
|
$-1.37M |
|
$-1.37M |
|
$-1.37M |
|
$0.12M |
|
$0.81M |
|
89.34M |
|
103.18M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$102.37M |
|
$23.60M |
|
$63.76M |
|
$166.13M |
|
$18.29M |
|
-- |
|
$5.56M |
|
$23.85M |
|
$142.28M |
|
$136.13M |
|
$142.28M |
|
91.31M |
|
| Cash Flow Statement Financials | |
$1.01M |
|
$-0.47M |
|
$24.38M |
|
$11.81M |
|
$37.07M |
|
$25.26M |
|
$7.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
95.31% |
|
0.31% |
|
0.31% |
|
-- |
|
-0.18% |
|
-4.63% |
|
$-0.15M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.17 |
|
1.19 |
|
|
Days Sales in Receivables |
75.76 |
-0.96% |
|
-1.00% |
|
-0.82% |
|
-0.96% |
|
$1.56 |
|
$-0.00 |
|
$0.01 |
|